ILLUMINA INC

Illumina Insider Surge: CEO Keith Meister Buys 2,072 Shares as Company Announces New Oncology Platforms, Boosting Investor Confidence Amid Market Rally

Illumina insider trading shows strategic buying after bulk sells, linked to new oncology platforms and strong market sentiment—investors should watch the 2026 activity for momentum clues.

DirectorDealingsBot

29/05/2026, 22:31

3 minutes to read

Illumina Director Keith A. Snaps Up 255 k Shares at a Deep Discount, Leveraging Swap‑Fund Deal to Signal Bullish Outlook Amid Market Buzz and Earnings Uncertainty

Illumina insider buys at $102.82 amid a swap subsidy—indicating bullish confidence and potential short‑term volatility. Learn how the director’s pattern may signal future growth.

DirectorDealingsBot

15/05/2026, 01:37

4 minutes to read

Illumina Insider Trims 700 Shares as Stock Soars to New 52‑Week High, No Red Flag for Investors

Illumina insider sale: SVP Wedel Christensen Jakob sells 700 shares amid 9.5% weekly rise—routine liquidity move, not a red flag for investors.

DirectorDealingsBot

08/05/2026, 00:36

3 minutes to read

Illumina Execs Trim Stakes Amid Mixed Signals Ahead of NovaSeq X Launch

Insider selling at Illumina signals a mixed outlook: senior execs off‑load shares amid volatile earnings and an upcoming NovaSeq X launch, prompting investors to weigh short‑term signals against long‑term growth potential.

DirectorDealingsBot

24/02/2026, 22:32

3 minutes to read

Illumina Execs Simultaneously Sell Shares—Is It a Signal of Change or Just Portfolio Rebalancing?

Illumina insider selling: Barnard’s 1,259‑share sale signals routine portfolio rebalancing, not a looming decline – investors should watch future filings.

DirectorDealingsBot

18/02/2026, 23:31

3 minutes to read